BRIEF published on 04/08/2025 at 23:26, 1 year 5 months ago Redcare Pharmacy N.V. Issues EUR 300 Million Bonds and Retires Part of Existing Debt Convertible Bonds Financial Strategy Redcare Pharmacy N.V. EUR 300 Million Debt Repurchase
BRIEF published on 04/08/2025 at 23:26, 1 year 5 months ago Redcare Pharmacy NV émet 300 millions d'euros d'obligations et rembourse une partie de sa dette existante Obligations Convertibles Stratégie Financière 300 Millions D'euros Pharmacie Redcare NV Rachat De Dette
BRIEF published on 04/08/2025 at 23:03, 1 year 5 months ago Semperit AG Holding Adjusts 2025 EBITDA Guidance Amid US Tariffs Semperit AG Holding US Tariffs EBITDA Adjustment 2025 Guidance Global Order Activity
BRIEF published on 04/08/2025 at 23:03, 1 year 5 months ago Semperit AG Holding ajuste ses prévisions d'EBITDA pour 2025 en raison des tarifs douaniers américains Semperit AG Holding Ajustement De L'EBITDA Orientations Pour 2025 Tarifs Douaniers Américains Activité Des Commandes Mondiales
BRIEF published on 04/08/2025 at 22:52, 1 year 5 months ago MicroVision to Host Retail Investor Day in Redmond Technology Solutions Investor Day Executive Team MicroVision Product Demonstrations
BRIEF published on 04/08/2025 at 22:52, 1 year 5 months ago MicroVision organise une journée dédiée aux investisseurs particuliers à Redmond MicroVision Solutions Technologiques Journée Des Investisseurs Équipe De Direction Démonstrations De Produits
BRIEF published on 04/08/2025 at 22:35, 1 year 5 months ago Forte Group to Convert Debt to Shares and Adjust Marketing Strategy Shares For Debt Debt Conversion Financial Strengthening Marketing Agreement Forte Group Strategy
BRIEF published on 04/08/2025 at 22:35, 1 year 5 months ago Le groupe Forte va convertir sa dette en actions et ajuster sa stratégie marketing Renforcement Financier Contrat De Commercialisation Actions Pour Dette Conversion De Dettes Stratégie Du Groupe Forte
BRIEF published on 04/08/2025 at 22:35, 1 year 5 months ago STMicroelectronics annonce une mise à jour des résolutions pour l'Assemblée Générale Annuelle 2025 Assemblée Générale Nomination Conseil De Surveillance STMicroelectronics Amsterdam
BRIEF published on 04/08/2025 at 22:35, 1 year 5 months ago STMicroelectronics Announces Updated Resolutions for 2025 Annual General Meeting Supervisory Board Appointment General Assembly STMicroelectronics Amsterdam
Published on 09/12/2026 at 02:35, 16 hours 46 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 20 hours 21 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 21 hours 16 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 21 hours 56 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 2 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 hour 31 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 11 hours 51 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 21 hours 6 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 21 hours 11 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 23 hours 37 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 23 hours ago Availability of the 2026 Interim Financial Report
